117 related articles for article (PubMed ID: 27822424)
1. Nuclear TBLR1 as an ER corepressor promotes cell proliferation, migration and invasion in breast and ovarian cancer.
Wu X; Zhan Y; Li X; Wei J; Santiago L; Daniels G; Deng F; Zhong X; Chiriboga L; Basch R; Xiong S; Dong Y; Zhang X; Lee P
Am J Cancer Res; 2016; 6(10):2351-2360. PubMed ID: 27822424
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic, full length and novel cleaved variant, TBLR1 reduces apoptosis in prostate cancer under androgen deprivation.
Daniels G; Zhang X; Zhong X; Santiago L; Wang LH; Wu X; Zhang JY; Liang F; Li X; Neubert TA; Steinke L; Shen Y; Basch R; Schneider R; Levy DE; Lee P
Oncotarget; 2016 Jun; 7(26):39556-39571. PubMed ID: 27127173
[TBL] [Abstract][Full Text] [Related]
3. Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation.
Wong MM; Guo C; Zhang J
Am J Clin Exp Urol; 2014; 2(3):169-87. PubMed ID: 25374920
[TBL] [Abstract][Full Text] [Related]
4. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
5. SUMOylation of TBL1 and TBLR1 promotes androgen-independent prostate cancer cell growth.
Park SY; Na Y; Lee MH; Seo JS; Lee YH; Choi KC; Choi HK; Yoon HG
Oncotarget; 2016 Jul; 7(27):41110-41122. PubMed ID: 27129164
[TBL] [Abstract][Full Text] [Related]
6. TBLR1 regulates the expression of nuclear hormone receptor co-repressors.
Zhang XM; Chang Q; Zeng L; Gu J; Brown S; Basch RS
BMC Cell Biol; 2006 Aug; 7():31. PubMed ID: 16893456
[TBL] [Abstract][Full Text] [Related]
7. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor coactivators that inhibit prostate cancer growth.
Daniels G; Jha R; Shen Y; Logan SK; Lee P
Am J Clin Exp Urol; 2014; 2(1):62-70. PubMed ID: 25374906
[TBL] [Abstract][Full Text] [Related]
9. TBL1XR1 in physiological and pathological states.
Li JY; Daniels G; Wang J; Zhang X
Am J Clin Exp Urol; 2015; 3(1):13-23. PubMed ID: 26069883
[TBL] [Abstract][Full Text] [Related]
10. A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation.
Ogawa S; Lozach J; Jepsen K; Sawka-Verhelle D; Perissi V; Sasik R; Rose DW; Johnson RS; Rosenfeld MG; Glass CK
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14461-6. PubMed ID: 15452344
[TBL] [Abstract][Full Text] [Related]
11. Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.
Havrilesky LJ; McMahon CP; Lobenhofer EK; Whitaker R; Marks JR; Berchuck A
J Soc Gynecol Investig; 2001; 8(2):104-13. PubMed ID: 11336882
[TBL] [Abstract][Full Text] [Related]
12. Nuclear corepressor and silencing mediator of retinoic and thyroid hormone receptors corepressor expression is incompatible with T(3)-dependent TRH regulation.
Becker N; Seugnet I; Guissouma H; Dupre SM; Demeneix BA
Endocrinology; 2001 Dec; 142(12):5321-31. PubMed ID: 11713232
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
Keeton EK; Brown M
Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
[TBL] [Abstract][Full Text] [Related]
14. Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation.
Qu C; He D; Lu X; Dong L; Zhu Y; Zhao Q; Jiang X; Chang P; Jiang X; Wang L; Zhang Y; Bi L; He J; Peng Y; Su J; Zhang H; Huang H; Li Y; Zhou S; Qu Y; Zhao Y; Zhang Z
J Hepatol; 2016 May; 64(5):1076-1089. PubMed ID: 26778753
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
16. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract][Full Text] [Related]
17. Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing.
Jonas BA; Varlakhanova N; Hayakawa F; Goodson M; Privalsky ML
Mol Endocrinol; 2007 Aug; 21(8):1924-39. PubMed ID: 17519355
[TBL] [Abstract][Full Text] [Related]
18. Reversible SUMOylation of TBL1-TBLR1 regulates β-catenin-mediated Wnt signaling.
Choi HK; Choi KC; Yoo JY; Song M; Ko SJ; Kim CH; Ahn JH; Chun KH; Yook JI; Yoon HG
Mol Cell; 2011 Jul; 43(2):203-16. PubMed ID: 21777810
[TBL] [Abstract][Full Text] [Related]
19. Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor.
Hong SH; Wong CW; Privalsky ML
Mol Endocrinol; 1998 Aug; 12(8):1161-71. PubMed ID: 9717842
[TBL] [Abstract][Full Text] [Related]
20. Nuclear tristetraprolin acts as a corepressor of multiple steroid nuclear receptors in breast cancer cells.
Barrios-García T; Gómez-Romero V; Tecalco-Cruz Á; Valadéz-Graham V; León-Del-Río A
Mol Genet Metab Rep; 2016 Jun; 7():20-6. PubMed ID: 27114912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
